Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) aa 250 to the C-terminus. The exact sequence is proprietary.
Database link: P51164
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab186749 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | 1/1000 - 1/10000. Detects a band of approximately 52 kDa (predicted molecular weight: 33 kDa). |
Blocking buffer: 5% NFDM/TBST
Blocking buffer: 5% NFDM/TBST
Blocking buffer: 5% NFDM/TBST
ab186749 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"